Frequency and severity of thrombocytopenia in patients with breast carcinoma during neoadjuvant chemotherapy in 2021

Sigita Hasnere; Pola Ļaksa

Frequency and severity of thrombocytopenia in patients with breast carcinoma during neoadjuvant chemotherapy in 2021

Sigita Hasnere
, Pola Ļaksa

The Faculty of Medicine and Life Sciences

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Journal	Medicina (Kaunas)
Volume	59
Publication status	Published - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

OECD Field of Science

3. Medical and Health Sciences

Cite this

TY - JOUR

T1 - Frequency and severity of thrombocytopenia in patients with breast carcinoma during neoadjuvant chemotherapy in 2021

AU - Hasnere, Sigita

AU - Ļaksa, Pola

PY - 2023

Y1 - 2023

UR - https://medicina.lsmuni.lt/abstracts-of-the-international-scientific-conference-on-medicine-organized-within-the-frame-of-the-81st-international-scientific-conference-of-the-university-of-latvia/

M3 - Meeting abstract

VL - 59

JO - Medicina (Kaunas)

JF - Medicina (Kaunas)

ER -

Frequency and severity of thrombocytopenia in patients with breast carcinoma during neoadjuvant chemotherapy in 2021

UN SDGs

OECD Field of Science

Other files and links

Cite this